ALKERMES - Precio De Mercado


Precio Día Año
Otsuka Holdings 4,405.00 -15.00 -0.34% -10.81%
AbbVie 110.52 -1.11 -0.99% 25.59%
Acadia Pharmaceuticals 53.66 -0.80 -1.47% 23.56%
Acorda Therapeutics 6.70 0.33 5.18% 223.67%
Amgen 245.49 3.83 1.58% 1.66%
Biogen 275.84 -4.45 -1.59% -3.38%
Bluebird Bio 50.53 -1.32 -2.55% -48.46%
BioMarin Pharmaceutical 82.97 1.61 1.98% -6.91%
Bristol-Myers Squibb 66.54 0.52 0.79% -0.27%
Coherus Biosciences 17.73 -0.26 -1.45% -10.75%
Gilead Sciences 63.33 0.93 1.49% 0.56%
GW Pharmaceuticals 135.73 -2.10 -1.52% 14.09%
Heron Therapeutics 17.64 -0.70 -3.82% -18.14%
Horizon Pharma 78.72 -0.19 -0.24% 105.59%
Ionis Pharmaceuticals 61.28 -0.07 -0.11% -0.24%
Intra Cellular Therapies 33.78 -0.36 -1.05% 28.69%
Jazz Pharmaceuticals 135.00 1.90 1.15% -10.86%
Johnson & Johnson 160.30 -0.35 -0.22% 8.16%
Eli Lilly 190.77 4.08 2.19% 34.89%
H Lundbeck A/S 228.00 5.90 2.66% 4.54%
Merck & Co 83.38 1.21 1.47% -8.34%
Marinus Pharmaceuticals 12.60 -0.13 -1.02% 447.83%
Neurocrine Biosciences 107.69 -1.60 -1.46% 2.89%
Minerva Neurosciences 2.71 0.02 0.74% -67.58%
Nektar Therapeutics 16.98 -0.82 -4.61% -24.47%
Pfizer 36.70 -0.05 -0.14% -9.41%
Regeneron Pharmaceuticals 517.93 0.02 0.004% 34.20%
Revance Therapeutics 28.64 -0.20 -0.69% 28.09%
Teva Pharmaceutical Industries 11.92 0.46 4.00% 16.86%
Vertex Pharmaceuticals 225.55 -0.57 -0.25% -4.36%
Zogenix 18.64 -0.33 -1.74% -66.10%


ALKS:US
Bienes
Efectivo Y Equivalentes
El Costo De Ventas
Activos Circulantes
Pasivo Circulante
DEUDA
EBIT
EBITDA
Empleados
Eps Ganancias Por Acción
Capital Y Las Reservas
Beneficio Bruto En Ventas
Los Gastos Financieros De La Deuda
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Capital Social Ordinario
Ingresos Por Ventas
Gastos De Venta Y Administración
Valores
Acreedores Comerciales
Deudores Comerciales